Registry of Haploidentical Hematopoietic Stem Cell Transplantation in Adult With Hematologic Disease - Trial NCT06286228
Access comprehensive clinical trial information for NCT06286228 through Pure Global AI's free database. This phase not specified trial is sponsored by Siriraj Hospital and is currently Not yet recruiting. The study focuses on Multiple Myeloma. Target enrollment is 43 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
Siriraj Hospital
Timeline & Enrollment
N/A
Apr 01, 2024
Apr 01, 2030
Primary Outcome
register hematologic patients with haploidentical hematopoietic stem cell transplantation
Summary
The goal of this observational study is to register hematologic patients with haploidentical
 hematopoietic stem cell transplantation (haploHSCT). The main questions it aims to answer
 are:
 
 - 1-year progression free survival rate
 
 - 1-year overall survival rate
 
 - Graft-versus-host free relapsed free survival at 30-day, 100-day, 180-day and 1-year
 
 - Chronic Graft-versus-host free relapsed free survival at 180-day and 1-year
 
 - Rate of Neutrophil and platelet engraftment
 
 - Efficacy of donor specific antibody desensitization
 
 - Relapsed rate
 
 - Primary and late graft failure
 
 - Safety and complication of haploHSCT
 
 - Complication of viral, bacterial, and fungal infection
 
 - Viral reactivation
 
 - Comparison outcomes between matched sibling donor (MSD) HSCT and matched unrelated donor
 (MUD) HSCT
 
 - Comparison cost-effectiveness of treatment between matched sibling donor (MSD) HSCT and
 matched unrelated donor (MUD) HSCT Participants will be collected the data of baseline
 diagnosis, treatment, treatment results of all admission and follow-up visits from
 hospital medical record.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06286228
Non-Device Trial